MAPS-Logo-2021-Primary-Horizontal-White-Background-1200x486.jpg
MAPS Releases Template to Assist in Federal Drug Sentencing Reform Efforts In January, the U.S. Sentencing Commission announced proposed amendments to federal drug sentencing guidelines, including lowering the highest base offense level for drug sentences.The proposal also...
MAPS-Logo-2021-Primary-Horizontal-White-Background-1200x486.jpg
MAPS Announces Search for New Executive Director as it Doubles Down on Advocacy and Movement Building MAPS’ next Executive Director will be a bold movement leader and visionary responsible for implementing MAPS' new strategic impact plan, ensuring programmatic excellence, advancing global expansion,...
MAPS-Logo-2021-Primary-Horizontal-White-Background-1200x486.jpg
MAPS Launches ‘Music is the Bridge’ Campaign Featuring Lil Yachty, Melissa Etheridge, Reggie Watts and More MAPS’ “Music is the Bridge” blends artist playlists & free psychedelic education, inspiring exploration and connection. Visit MAPS.org/music-is-the-bridge
MAPS-Logo-2021-Primary-Horizontal-White-Background-1200x486.jpg
Psychedelic Science 2025 Conference Announces Workshops, Holiday Sale, and Scholarship Deadline World’s leading psychedelic conference kicks off with workshops from leaders in science, medicine, therapy, policy, Indigenous medicine, and societyUpcoming deadline: speaker submissions, initial...
MAPS-Logo-2021-Primary-Horizontal-White-Background-1200x486.jpg
MAPS Successfully Clears Path for Cannabis Research through FDA Formal Dispute After three years of negotiation with the FDA, MAPS has successfully secured FDA clearance to conduct a clinical trial, MJP2, to examine the use of smoked cannabis for the treatment of PTSD symptoms...
MAPS-Logo-2021-Primary-Horizontal-White-Background-1200x486.jpg
MAPS Awards Grant for Pilot MDMA-assisted Massed Exposure Therapy Trial MAPS, which has incubated and funded cutting-edge psychedelic research for decades, is continuing to advance our understanding of psychedelic-assisted therapiesThis study is one of the first trials...
MAPS-Logo-2021-Primary-Horizontal-White-Background-1200x486.jpg
MAPS Statement on FDA Complete Response Letter for MDMA-Assisted Therapy for PTSD New Drug Application MAPS remains confident in its goal of making access to MDMA-assisted therapy for PTSD safe and legal SAN JOSE, Calif., Aug. 09, 2024 (GLOBE NEWSWIRE) -- The Multidisciplinary Association for...
MAPS-Logo-2021-Primary-Horizontal-White-Background-1200x486.jpg
Three Pivotal Drug Policy Organizations Hold Media Briefing/Q&A on DEA Rescheduling of Cannabis WASHINGTON, May 01, 2024 (GLOBE NEWSWIRE) -- What: The Multidisciplinary Association for Psychedelic Studies (MAPS), The Marijuana Policy Project (MPP), and the National Organization for the...
MAPS-Logo-2021-Primary-Horizontal-White-Background-1200x486.jpg
MAPS Provides Psychedelic Crisis Assessment and Intervention Training to Denver’s First Responders MAPS uses its over 30 years of experience in the psychedelic space to offer a first-of-its-kind gold-standard training program.
MAPS-Logo-2021-Primary-Horizontal-White-Background-1200x486.jpg
MAPS Announces Celestial Plans for Its 38th Anniversary MAPS, which celebrates its 38th anniversary on April 8, will celebrate with a total solar eclipse at the Texas Eclipse 2024 festival in Texas